Literature DB >> 26511485

A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Alain Philippon1, Patrick Slama2, Paul Dény3, Roger Labia4.   

Abstract

For medical biologists, sequencing has become a commonplace technique to support diagnosis. Rapid changes in this field have led to the generation of large amounts of data, which are not always correctly listed in databases. This is particularly true for data concerning class A β-lactamases, a group of key antibiotic resistance enzymes produced by bacteria. Many genomes have been reported to contain putative β-lactamase genes, which can be compared with representative types. We analyzed several hundred amino acid sequences of class A β-lactamase enzymes for phylogenic relationships, the presence of specific residues, and cluster patterns. A clear distinction was first made between dd-peptidases and class A enzymes based on a small number of residues (S70, K73, P107, 130SDN132, G144, E166, 234K/R, 235T/S, and 236G [Ambler numbering]). Other residues clearly separated two main branches, which we named subclasses A1 and A2. Various clusters were identified on the major branch (subclass A1) on the basis of signature residues associated with catalytic properties (e.g., limited-spectrum β-lactamases, extended-spectrum β-lactamases, and carbapenemases). For subclass A2 enzymes (e.g., CfxA, CIA-1, CME-1, PER-1, and VEB-1), 43 conserved residues were characterized, and several significant insertions were detected. This diversity in the amino acid sequences of β-lactamases must be taken into account to ensure that new enzymes are accurately identified. However, with the exception of PER types, this diversity is poorly represented in existing X-ray crystallographic data.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26511485      PMCID: PMC4771212          DOI: 10.1128/CMR.00019-15

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  196 in total

1.  Molecular and biochemical characterization of a novel class A beta-lactamase (HER-1) from Escherichia hermannii.

Authors:  Anne Beauchef-Havard; Guillaume Arlet; Valerie Gautier; Roger Labia; Patrick Grimont; Alain Philippon
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 2.  Extended-spectrum beta-lactamases: structure and kinetic mechanism.

Authors:  M G P Page
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

3.  Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.

Authors:  Djalal Meziane-Cherif; Dominique Decré; E Arne Høiby; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

4.  Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.

Authors:  Feng Wang; Craig Cassidy; James C Sacchettini
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.

Authors:  S Mariotte-Boyer; M H Nicolas-Chanoine; R Labia
Journal:  FEMS Microbiol Lett       Date:  1996-09-15       Impact factor: 2.742

Review 6.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

Authors:  A A Medeiros
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

7.  Inhibition of beta-lactamase by clavulanate. Trapped intermediates in cryocrystallographic studies.

Authors:  C C Chen; O Herzberg
Journal:  J Mol Biol       Date:  1992-04-20       Impact factor: 5.469

8.  Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum.

Authors:  S Bellais; L Poirel; T Naas; D Girlich; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

9.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

10.  Crystal structure of the extended-spectrum β-lactamase PER-2 and insights into the role of specific residues in the interaction with β-lactams and β-lactamase inhibitors.

Authors:  Melina Ruggiero; Frédéric Kerff; Raphaël Herman; Frédéric Sapunaric; Moreno Galleni; Gabriel Gutkind; Paulette Charlier; Eric Sauvage; Pablo Power
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

View more
  29 in total

Review 1.  Past and Present Perspectives on β-Lactamases.

Authors:  Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 2.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

3.  Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.

Authors:  Orville A Pemberton; Radwan E Noor; Vasantha Kumar M V; Ruslan Sanishvili; M Trent Kemp; Fiona L Kearns; H Lee Woodcock; Ioannis Gelis; Yu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

4.  Enterobacter cloacae Complex Isolates Harboring blaNMC-A or blaIMI-Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and Plasmids.

Authors:  David A Boyd; Laura F Mataseje; Ross Davidson; Johannes A Delport; Jeff Fuller; Linda Hoang; Brigitte Lefebvre; Paul N Levett; Diane L Roscoe; Barbara M Willey; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

5.  Natural and Synthetic Suppressor Mutations Defy Stability-Activity Tradeoffs.

Authors:  Sonya Lee; Cynthia N Okoye; Devin Biesbrock; Emily C Harris; Katelyn F Miyasaki; Ryan G Rilinger; Megalan Tso; Kathryn M Hart
Journal:  Biochemistry       Date:  2022-02-10       Impact factor: 3.162

Review 6.  Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.

Authors:  Claire Amaris Hobson; Gautier Pierrat; Olivier Tenaillon; Stéphane Bonacorsi; Béatrice Bercot; Ella Jaouen; Hervé Jacquier; André Birgy
Journal:  Antimicrob Agents Chemother       Date:  2022-08-18       Impact factor: 5.938

7.  Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases.

Authors:  Fredrika Rajer; Lisa Allander; Philip A Karlsson; Linus Sandegren
Journal:  Antimicrob Agents Chemother       Date:  2022-06-02       Impact factor: 5.938

Review 8.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

9.  Regulation of Class A β-Lactamase CzoA by CzoR and IscR in Comamonas testosteroni S44.

Authors:  Weiping Zhuang; Hongliang Liu; Jingxin Li; Lu Chen; Gejiao Wang
Journal:  Front Microbiol       Date:  2017-12-22       Impact factor: 5.640

Review 10.  A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous.

Authors:  Apostolos Liakopoulos; Dik Mevius; Daniela Ceccarelli
Journal:  Front Microbiol       Date:  2016-09-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.